Unaudited Standalone Financial Result for the Quarter and Half year ended as on 30th September, 2025
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 0.4 pts more than Nifty Microcap 250 and 0.5 pts more than its Commodity Chemicals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Padmanabh Industries reported a sharp deterioration in Q2 FY26 with revenue from operations falling to ₹11.50 lacs from ₹24.75 lacs in Q2 FY25 (~54% YoY decline). For H1 FY26, revenue collapsed to ₹11.50 lacs versus ₹36.51 lacs in H1 FY25, a drop of nearly 69%. The company swung to a wider net loss of ₹(19.39) lacs in Q2 (vs ₹(2.05) lacs loss) and ₹(21.44) lacs for H1 (vs ₹(6.61) lacs). The balance sheet shows negative equity of ₹(26.22) lacs with deeply eroded reserves of ₹(633.97) lacs and total borrowings of around ₹652 lacs (long-term borrowings jumped to ₹362.53 lacs from ₹60.99 lacs). The auditor flagged an Emphasis of Matter regarding pending verification of trade receivables, payables, loans, and investments, and absence of GSTN during the period.
This is a weak result for shareholders — revenue is shrinking sharply, losses are deepening, and the balance sheet is stressed with negative net worth and surging debt, raising serious solvency and going-concern concerns despite a positive operating cash flow driven by loan recoveries.